Teladoc Health (TDOC) Liabilities and Shareholders Equity (2014 - 2026)

Teladoc Health's Liabilities and Shareholders Equity history runs 13 years deep, the most recent figure standing at $2.8 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 18.5% year-over-year to $2.8 billion; the TTM figure through Mar 2026 stood at $11.4 billion (down 18.38% YoY), while the FY2025 annual figure was $2.9 billion, down 18.72% from the prior year.
• Liabilities and Shareholders Equity came in at $2.8 billion for Q1 2026 at Teladoc Health, down from $2.9 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $11.1 billion in Q1 2022 to a low of $2.8 billion in Q1 2026.
• A 5-year average of $4.6 billion and a median of $4.3 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity plunged 75.5% in 2022 and climbed 1.08% in 2023, its largest moves.
• Teladoc Health's Liabilities and Shareholders Equity stood at $4.3 billion in 2022, then grew by 1.08% to $4.4 billion in 2023, then retreated by 19.94% to $3.5 billion in 2024, then dropped by 18.72% to $2.9 billion in 2025, then decreased by 1.79% to $2.8 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.8 billion, $2.9 billion, and $2.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison